HealthBBCNYTNPR+8globe-and-maillsm-lvYahoobalkan-webnewsbeastThe Weektaiwan-newsmyjoyonline14h ago11 sources
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
The U.S. Food and Drug Administration has approved a breakthrough pancreatic cancer treatment that clinical trials show extends patient survival to a median of 13.2 months, marking a major advancement for one of the most difficult-to-treat cancers.